At a glance
ClinicalIndex Comparison RecordN/ACompleted· 219 enrolled
Drug / intervention
NINJA 3 Investigational Blood Glucose Monitoring Systemdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Performance of the Ninja 3 Blood Glucose Monitoring System
In Brief
A clinical study evaluating NINJA 3 Investigational Blood Glucose Monitoring System for Diabetes. Completed, enrolled 219 participants across 2 sites.
Detailed Summary
The purpose of this study was to determine if untrained subjects who have diabetes can operate the Investigational Blood Glucose Monitoring System (BGMS) and obtain valid glucose results.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsDiabetes
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
20132014201520162017201820192020202120222023202420252026
Enrollment StartApr 2013
Primary CompletionMay 2013
First PostedMay 2013
TodayJul 2026
First PostedMay 22, 2013
Enrollment StartApr 1, 2013
Primary CompletionMay 1, 2013
TodayJul 2, 2026
Enrollment to primary: 1 monthPosted 13.1 years ago
Interventions
NINJA 3 Investigational Blood Glucose Monitoring Systemdevice
Untrained subjects with diabetes self-tested capillary fingerstick and palm blood using the NINJA 3 Investigational Blood Glucose Monitoring System. Study staff tested subject fingerstick blood. All BG results were compared to reference method results obtained from subject capillary plasma.